Please assess the completion status of the following clinical trial:

Trial Title: A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female 18 years or older who has been hospitalised for chest pain and potential ACS~* Females of child-bearing potential must have a negative pregnancy test at enrollment and be willing to use 2 methods of reliable contraception~Exclusion Criteria:~* Persons with moderate or severe liver disease~* Persons who have already been treated with an invasive (angioplasty) procedure for the current episode of ACS~* Persons who are being treated with blood clotting agents that cannot be stopped

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Clopidogrel (Type: ACTIVE_COMPARATOR): Oral treatment
- Ticagrelor (Type: EXPERIMENTAL): Oral treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).